Age-Related Adaptive Immune Changes in Parkinson’s Disease
Open accessThe DOI matches its Crossref record; 93 of the 94 references it cites were found in a registry or an index.
Abstract
Ageing is a major risk factor for most neurodegenerative diseases, including Parkinson’s disease (PD). Progressive age-related dysregulation of the immune system is termed immunosenescence and is responsible for the weakened response to novel antigens, increased susceptibility to infections and reduced effectiveness of vaccines seen in the elderly. Immune activation, both within the brain and periphery, is heavily implicated in PD but the role of immunosenescence has not been fully explored. Studies to date provide some evidence for an attenuation in immunosenescence in PD, particularly a reduction in senescent CD8 T lymphocytes in PD cases compared to similarly aged controls. Here, we discuss recent evidence of age-related immune abnormalities in PD with a focus on T cell senescence and explore their potential role in disease pathogenesis and development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, during abnormal immune ageing, the typical age-associated shift towards senescence in the CD8+ T-cell population may be attenuated, resulting in a heightened immune response to misfolded α-syn and thereby increasing the risk of PD.333”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [333]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622 · cited 1×
“Both alpha-synuclein pathology and microbial changes in the gut have also been implicated in driving a proinflammatory state in PD [66, 67].”
BackgroundAgeing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310 · cited 1×
“Ageing is characterized by a gradual deterioration of biological functions and is the main risk factor for multiple pathological conditions, such as cardiovascular disease [1], cancer [2], and neurodegenerative disorders [3].”
BackgroundAssociation between telomere length in blood and mortality in people aged 60 years or older
Cawthon, R. M., Smith, K. R., O'Brien, E., Sivatchenko, A., & Kerber, R. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12384-7 · Cited by 1,761 · cited 1×
“found a significantly higher mortality rate in people whose leucocytes had the greatest degree of telomere erosion [47].”
BackgroundBrochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Postuma, R. B., Iranzo, A., Hu, M., Högl, B., Boeve, B. F., Manni, R., Oertel, W. H., Arnulf, I., Ferini-Strambi, L., Puligheddu, M., et al. (2019) · Brain · doi:10.1093/brain/awz030 · Cited by 1,106 · cited 1×
“Interestingly, a proteomic study in a small group of patients with REM sleep behaviour disorder (who have a 60–81% likelihood of developing parkinsonism/dementia within 10 years) [55, 56] has reported a significant upregulation of CRP as well as other immune-related molecules in patients versus controls, thus implicat…”
BackgroundBrenchley, J. M., Karandikar, N. J., Betts, M. R., Ambrozak, D. R., Hill, B. J., Crotty, L. E., Casazza, J. P., Kuruppu, J., Migueles, S. A., Connors, M., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2103 · Cited by 1,073
Antibody response to influenza vaccination in the elderly: A quantitative review
GOODWIN, K., VIBOUD, C., & SIMONSEN, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.08.105 · Cited by 1,064 · cited 1×
“Immunosenescence contributes to increased susceptibility to infections, reduced effectiveness of vaccines [4], as well as increased prevalence of autoimmunity and inflammatory conditions in the elderly [5].”
BackgroundClonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease
Gate, D., Saligrama, N., Leventhal, O., Yang, A. C., Unger, M. S., Middeldorp, J., Chen, K., Lehallier, B., Channappa, D., De Los Santos, M. B., et al. (2020) · Nature · doi:10.1038/s41586-019-1895-7 · Cited by 992 · cited 1×
“RAs in the CSF of patients versus controls [70].”
BackgroundGoodwin, V. A., Richards, S. H., Taylor, R. S., Taylor, A. H., & Campbell, J. L. (2008) · Movement Disorders · doi:10.1002/mds.21922 · Cited by 922 · cited 1×
“, gait speed, balance) [90, 91] and cognitive/neuropsychiatric symptoms, such as global cognition [92, 93] and depression [94], and may have the potential to slow down the progression of the disease.”
BackgroundT cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
Cited by
The pathogenesis of Parkinson's disease
Morris, H. R., Spillantini, M. G., Sue, C. M., & Williams-Gray, C. H. (2024) · The Lancet · doi:10.1016/s0140-6736(23)01478-2 · Cited by 1,019
Self-citationAntiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“…the CD8 + T-cell population may be attenuated, resulting in a heightened immune response to misfolded α -syn and thereby increasing the risk of PD. 333 Similarly, in a single-centre, retrospective study, increased numbers of senescent and late memory T and B lymphocytes were characteristic of…”
InfluentialLv, Q.-K., Tao, K., Wang, X.-B., Yao, X., Pang, M., Liu, J., Wang, F., & Liu, C. (2023) · Inflammation Research · doi:10.1007/s00011-022-01676-x · Cited by 127
“As age is the main risk factor for PD [26], the microglia in the brain of older people present changes in morphology, phenotype, inflammation and overall functional response.”
BackgroundZaccai, S., Nemirovsky, A., Lerner, L., Alfahel, L., Eremenko, E., Israelson, A., & Monsonego, A. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-03007-1 · Cited by 25
“Such impact of age-related dysregulated T-cell effector functions were recently observed in patients with ALS [29] and several neurodegenerative processes such as MS [54], PD [55], and AD [56].”
BackgroundMapping the peripheral immune landscape of Parkinson’s disease patients with single-cell sequencing
Moquin‐Beaudry, G., Andriamboavonjy, L., Audet, S., Hamilton, L. K., Duquette, A., Chouinard, S., Panisset, M., & Tétreault, M. (2025) · Brain · doi:10.1093/brain/awaf066 · Cited by 25
Senescent T Cells in Age-Related Diseases
Yu, P.-J., Zhou, M. L., Liu, Y., & Du, J. (2024) · Aging and Disease · doi:10.14336/ad.2024.0219 · Cited by 22
“Research on the correlation between T-cell senescence markers and indicators of Parkinson's disease (PD) progression is lacking; however, PD cohorts at different disease stages have shown comparable reductions in terminally differentiated T cells [170].”
Kulski, J. K., Suzuki, S., Shiina, T., Pfaff, A. L., & Kõks, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1349030 · Cited by 18
“…causes of PD may involve genetic, environmental, metabolic and immunological factors with various non-neurological features and varying overlap with age-related autoimmune diseases such as multiple sclerosis, amyotrophic lateral sclerosis, thyroid diseases and rheumatoid myalgia (3, 8 – 11).”
BackgroundBendig, J., Frank, A. K., & Reichmann, H. (2024) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2023.36 · Cited by 18
Ageing-related changes in the regulation of microglia and their interaction with neurons
Rommy von Bernhardi, M., & Eugenín, J. L. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110241 · Cited by 10
Wang, J., Lin, S., Bai, C., Zhang, H., Liu, H., Wang, M., & Guo, R. (2025) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf033 · Cited by 10
“39,40 Second, both antiparkinsonian drugs and APs may affect the composition of gut microbiota, and dysbiosis can alter metabolic responses in the gut, leading to systemic inflammation that spreads from the gut to peripheral blood and may cross the blood-brain barrier to affect the central nervous…”
Hart, M., Conrad, J., Barrett, E., Legg, K., Ivey, G., Lee, P. H. U., Yung, Y. C., & Shim, J. W. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114433 · Cited by 6
Declining incidence of Parkinson’s disease in Israel (2002–2021)
Balash, Y., Zohar, T., Gilad, R., Eilam, A., & Korczyn, A. D. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02984-2 · Cited by 5
“…response to novel antigens and increased susceptibility to infections, there is evidence for an attenuation in immunosenescence in PD, particularly for a reduction in senescent CD8 T lymphocytes, which may indicate a modification of the immu - nological response in the elderly (Kouli et al., 2022).”
Linking Immune Activation and Parkinson’s Disease
Bloem, B. R., Brundin, P., Harms, A. S., Arlehamn, C. S. L., Tan, E., & Williams‐Gray, C. H. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-229005 · Cited by 4
“T lymphocyte subsets are altered, with a shift towards pro-inflammatory Th1 and Th17 cells in PD, and with an attenuation of age-related senescent changes in CD8+ T-cells [8].”
Self-citationNeutrophil‐to‐Lymphocyte Ratio Predicts Anxiety Progression in Parkinson's Disease
Yang, D., Liu, Z., Lin, S., Wang, J., Zhang, S., Xu, J., Cai, H., Zhang, B., Lin, H., Huang, S., et al. (2026) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70519 · Cited by 1
“30,31 Translating these fi ndings into clinical practice holds tangible promise.”
Cellular Senescence in Parkinson’s Disease (PD)
Afzal, M. (2025) · Springer eBooks · doi:10.1007/978-981-96-8873-9_7
Immunopathogenesis of Parkinson’s Disease: From Peripheral Inflammation to Neurodegeneration
Aakash, A., Abdalla, A., Ismail, H., malik, M. K., Ghani, M. U., Ahmed, M., el Hamid, A. S. A., & Rathi, L. (2025) · Journal of Carcinogenesis · doi:10.64149/j.carcinog.24.10s.28-33
Zaccai, S., Nemirovsky, A., Lerner, L., Alfahel, L., Eremenko, E., Israelson, A., & Monsonego, A. (2024) · Figshare · doi:10.6084/m9.figshare.26666419
Zaccai, S., Nemirovsky, A., Lerner, L., Alfahel, L., Eremenko, E., Israelson, A., & Monsonego, A. (2024) · Figshare · doi:10.6084/m9.figshare.26666413
Zaccai, S., Nemirovsky, A., Lerner, L., Alfahel, L., Eremenko, E., Israelson, A., & Monsonego, A. (2024) · Figshare · doi:10.6084/m9.figshare.26666422
Zaccai, S., Nemirovsky, A., Lerner, L., Alfahel, L., Eremenko, E., Israelson, A., & Monsonego, A. (2024) · Figshare · doi:10.6084/m9.figshare.26666410
Zaccai, S., Nemirovsky, A., Lerner, L., Alfahel, L., Eremenko, E., Israelson, A., & Monsonego, A. (2024) · Figshare · doi:10.6084/m9.figshare.26666416
Zaccai, S., Nemirovsky, A., Lerner, L., Alfahel, L., Eremenko, E., Israelson, A., & Monsonego, A. (2024) · Figshare · doi:10.6084/m9.figshare.26666407
Zaccai, S., Nemirovsky, A., Lerner, L., Alfahel, L., Eremenko, E., Israelson, A., & Monsonego, A. (2024) · Figshare · doi:10.6084/m9.figshare.26666425
PISTONE, A. (2026) · CINECA IRIS Institutional Research Information System (University of Basilicata)
The role of immune aging in rheumatoid arthritis and its clinical and therapeutic significance
Wei, Y., Qi, W., Li, P., Wang, T., Wang, Z., Liu, H., Zhang, Y., 田杰祥, & Wang, G. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117531
Metadata
- Authors
- Kouli, A., & Williams-Gray, C. H.
- Affiliations
- University of Cambridge (GB)
- Department of Clinical Neurosciences, University of Cambridge, John Van Geest Centre for Brain Repair, Cambridge, UK
- Corresponding author
- Kouli, Antonina
- ORCID
- Kouli, Antonina
- Venue
- Journal of Parkinson's Disease
- Publisher
- SAGE Publications
- Published
- 2022-09-27
- Volume
- 12
- Issue
- s1
- Pages
- S93-S104
- ISSN
- 1877-7171 (ISSN-L)
- 1877-718X
- PMC
- PMC9535571
- OpenAlex
- W4281741142
- Cited by
- 20
- References
- 94
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 10 · 2023: 2 · 2022: 1
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Parkinson s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc)
- Apollo (cc-by)
- Funders
- UK Research and Innovation
- National Institute for Health and Care Research ([IS-BRC-1215-20014, BRC1215-20014)
- Research Councils UK
- Medical Research Council (MR/R007446/1, BRC-1215-20014)
- NIHR Cambridge Biomedical Research Centre ((BRC-1215-20014))
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- Parkinson's disease, immunosenescence, age-related immune changes, T cell senescence, CD8+ T cells, neuroinflammation, neurodegeneration, pathogenesis
- MeSH terms
- Immunosenescence, Aged, Aging, Humans, Parkinson Disease, T-Lymphocytes, Cellular Senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.